Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Vanda Pharmaceuticals stock
Learn how to easily invest in Vanda Pharmaceuticals stock.
Vanda Pharmaceuticals Inc is a biotechnology business based in the US. Vanda Pharmaceuticals shares (VNDA) are listed on the NASDAQ and all prices are listed in US Dollars. Vanda Pharmaceuticals employs 278 staff and has a trailing 12-month revenue of around $262.7 million.
How to buy shares in Vanda Pharmaceuticals
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – VNDA – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Vanda Pharmaceuticals stock price (NASDAQ: VNDA)Use our graph to track the performance of VNDA stocks over time.
Vanda Pharmaceuticals shares at a glance
|Latest market close||$9.88|
|52-week range||$9.24 - $21.44|
|50-day moving average||$10.48|
|200-day moving average||$11.83|
|Wall St. target price||$11.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$0.19|
Buy Vanda Pharmaceuticals shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Vanda Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Vanda Pharmaceuticals price performance over time
|1 week (2022-09-23)||2.17%|
|1 month (2022-09-01)||-8.60%|
|3 months (2022-07-01)||-11.71%|
|6 months (2022-04-01)||-16.48%|
|1 year (2021-10-01)||-44.43%|
|2 years (2020-10-01)||9.88|
|3 years (2019-10-01)||12.95|
|5 years (2017-09-29)||17.9|
Is Vanda Pharmaceuticals stock undervalued or overvalued?
Valuing Vanda Pharmaceuticals stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Vanda Pharmaceuticals's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Vanda Pharmaceuticals's P/E ratio
Vanda Pharmaceuticals's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 51x. In other words, Vanda Pharmaceuticals shares trade at around 51x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Vanda Pharmaceuticals's EBITDA
Vanda Pharmaceuticals's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $18.1 million.
The EBITDA is a measure of a Vanda Pharmaceuticals's overall financial performance and is widely used to measure a its profitability.
Vanda Pharmaceuticals financials
|Revenue TTM||$262.7 million|
|Operating margin TTM||5.8%|
|Gross profit TTM||$243.1 million|
|Return on assets TTM||1.62%|
|Return on equity TTM||2.22%|
|Market capitalisation||$546.9 million|
TTM: trailing 12 months
Vanda Pharmaceuticals share dividends
We're not expecting Vanda Pharmaceuticals to pay a dividend over the next 12 months.
Vanda Pharmaceuticals share price volatility
Over the last 12 months, Vanda Pharmaceuticals's shares have ranged in value from as little as $9.24 up to $21.44. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Vanda Pharmaceuticals's is 0.4682. This would suggest that Vanda Pharmaceuticals's shares are less volatile than average (for this exchange).
Vanda Pharmaceuticals overview
Vanda Pharmaceuticals Inc. , a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under development include HETLIOZ (tasimelteon) for the treatment of jet lag disorder, smith-magenis syndrome, pediatric Non-24, autism spectrum, and delayed sleep phase disorder; Fanapt (iloperidone) for the treatment of bipolar disorder and a long acting injectable formulation program for the treatment of schizophrenia; and Tradipitant (VLY-686), a small molecule neurokinin-1 receptor (NK-1R) antagonist, for the treatment of atopic dermatitis, gastroparesis, and motion sickness. The company's products under development also comprise VTR-297, a small molecule histone deacetylase inhibitor for the treatment of hematologic malignancies and with potential use as a treatment for various oncology indications; VQW-765, a small molecule nicotinic acetylcholine receptor partial agonist for the treatment of psychiatric disorders; a portfolio of cystic fibrosis transmembrane conductance regulator activators and inhibitors for the treatment of dry eye and ocular inflammation, as well as BPO-27 for the treatment of secretory diarrhea disorders, including cholera; and VHX-896, the active metabolite of iloperidone. It markets its products in the United States, Europe, and Israel. Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals in the news
Vanda Pharmaceuticals and OliPass Announce Strategic Partnership to Develop Antisense Oligonucleotide Therapeutics
Vanda Pharmaceuticals Announces Participation in the H.C. Wainwright Global Investment Conference
VANDA PHARMACEUTICALS ANNOUNCES NOTICE OF OPPORTUNITY FOR AN FDA HEARING ON THE sNDA FOR HETLIOZ® IN JET LAG DISORDER
Frequently asked questionsWhat percentage of Vanda Pharmaceuticals is owned by insiders or institutions?
Currently 3.668% of Vanda Pharmaceuticals shares are held by insiders and 102.501% by institutions. How many people work for Vanda Pharmaceuticals?
Latest data suggests 278 work at Vanda Pharmaceuticals. When does the fiscal year end for Vanda Pharmaceuticals?
Vanda Pharmaceuticals's fiscal year ends in December. Where is Vanda Pharmaceuticals based?
Vanda Pharmaceuticals's address is: 2200 Pennsylvania Avenue NW, Washington, DC, United States, 20037 What is Vanda Pharmaceuticals's ISIN number?
Vanda Pharmaceuticals's international securities identification number is: US9216591084 What is Vanda Pharmaceuticals's CUSIP number?
Vanda Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 921659108
More guides on Finder
Alternatives to Webull
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
Best renewable energy stocks for 2022
Here are the best renewable energy stocks that should be on your radar to help you grow your green portfolio
Here are 6 manganese stocks that should be on your radar as EV batteries create new demand.
The best dividend stocks for 2022
Our list of 10 dividend stocks to watch in 2022.
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
Ask an Expert